Related Experiment Video
Updated: Jun 20, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Downregulation of protease activated receptor expression and cytokine production in P815 cells by RNA interference
Liya Qiao1, Huiyun Zhang, Shandong Wu
1Allergy and Inflammation Research Institute, Shantou University Medical College, 22 Xin-ling Road, Shantou, Guangdong 515041, PR China. qlyabc@sina.com.cn
Background:
Protease-activated receptors (PAR) are seven transmembrane G-coupled receptors comprising four genes (PAR-1 approximately PAR-4). Mast cell has been identified to be able to express PARs and release an array of cytokines upon activation. Recently, it was reported that interleukin (IL)-12 could regulate the expression of PARs in mast cells, and tryptase could induce IL-4 and IL-6 release from mast cells. In order to further investigate the issues, RNA interference (RNAi) technique was employed and small interfering RNAs (siRNA) of PARs were transfected in P815 cells.
Results:
The results showed that siRNAs for PAR-1, PAR-2 and PAR-4 significantly downregulated expression of PAR-1, PAR-2 and PAR-4 mRNAs and proteins in P815 cells at 24, 48 and 72 h following transfection. siRNA PAR-1.2 and siRNA PAR-4.2 significantly reduced IL-12 induced upregulation of PAR-1 and PAR-4 expression, respectively when P815 cells were transfected with them for 48 h. siRNA PAR-2.3 blocked IL-12 induced downregulation of PAR-2 expression on both mRNA and protein levels. It was also observed that siRNA PAR-2.3 and siRNA PAR-1.2 reduced trypsin induced IL-4 release by approximately 92.6% and 65.3%, and SLIGKV-NH2 induced IL-4 release by 82.1% and 60.1%, respectively. Similarly, siRNA PAR-2.3 eliminated tryptase-induced IL-4 release by 75.3%, and siRNA PAR-1.2 diminished SFLLR-NH2 induced IL-4 release by 79.3%. However, siRNA PAR-1.2, siRNA PAR-2.3 and siRNA PAR-4.3 at 10 nM did not show any effect on tryptase-induced IL-6 release from P815 cells.
Conclusion:
In conclusion, siRNAs of PARs can modulate PAR expression and PAR related cytokine production in mast cells, confirming that PARs are likely to play a role in allergic reactions.
Insights
Small interfering RNAs (siRNAs) targeting protease-activated receptors (PARs) effectively modulated PAR expression and cytokine release in mast cells. This confirms the role of PARs in allergic reactions.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Protease-activated receptors (PARs) are G-protein coupled receptors involved in cellular signaling.
- Mast cells express PARs and release cytokines upon activation.
- Interleukin (IL)-12 and tryptase influence PAR expression and cytokine release in mast cells.
Purpose of the Study:
- To investigate the role of PARs in mast cell activation and cytokine production.
- To determine the efficacy of small interfering RNAs (siRNAs) in modulating PAR expression.
- To assess the impact of PAR modulation on IL-4 and IL-6 release.
Main Methods:
- Utilized RNA interference (RNAi) with specific siRNAs targeting PAR-1, PAR-2, and PAR-4 in P815 mast cells.
- Transfected cells with siRNAs and analyzed PAR mRNA and protein expression at 24, 48, and 72 hours.
- Stimulated cells with IL-12, trypsin, tryptase, or PAR-activating peptides (SLIGKV-NH2, SFLLR-NH2) to measure cytokine release.
Main Results:
- siRNAs significantly downregulated PAR-1, PAR-2, and PAR-4 expression at both mRNA and protein levels.
- Specific siRNAs reduced IL-12-induced changes in PAR expression.
- siRNA targeting PAR-2 and PAR-1 significantly inhibited trypsin- and peptide-induced IL-4 release, and tryptase-induced IL-4 release.
Conclusions:
- siRNAs effectively modulate PAR expression in mast cells.
- PARs play a significant role in mast cell-mediated cytokine production, particularly IL-4 release.
- These findings support the involvement of PARs in allergic inflammatory responses.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

